title: Neurocognitive impairments in brain tumor patients.
abstract: There is an increased scientific interest in cognitive impairments caused by brain tumors during the last decade. It has lead to the introduction and routine clinical usage of neuropsychological test batteries in brain tumor patients, thus making them an important clinical measure for the assessment of the efficacy of the different treatment regimens such as surgery, radiotherapy and chemotherapy. The effect of cognitive deficit on patients' quality of life and survival has been unequivocally proven. These are among the most common neurological symptoms associated with brain tumors. The improvement in cognitive function and delay in neurocognitive decline are acceptable endpoints in clinical trials. Cognition has been demonstrated to be an independent predictor of survival in patients with cerebral neoplasms.
authors: Department of Neurosurgery, Medical University, Plovdiv, Bulgaria. dr.kehayov@gmail.com
authors: Ivo I
authors: II
authors: Kehayov
authors: Borislav D
authors: BD
authors: Kitov
authors: Christo B
authors: CB
authors: Zhelyazkov
authors: Stefan D
authors: SD
authors: Raykov
authors: Atanas N
authors: AN
authors: Davarski
mesh_terms: D001932:Brain Neoplasms / Q000150:complications* / Q000401:mortality / Q000523:psychology; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology* / Q000523:psychology; D003657:Decision Making; D006801:Humans; D009483:Neuropsychological Tests / Q000592:standards; D057240:Patient Preference; D011237:Predictive Value of Tests; D011788:Quality of Life; D015996:Survival Rate